Angehefteter Tweet

DelixLabs
426 posts

@DelixLabs
For research use only. Exploring the science, mechanisms, and latest research on peptides. Educational resources, study summaries & literature. →



























RETATRUTIDE IS ABSOLUTELY SENDING CHOLESTEROL TO THE SHADOW REALM 🔥 Triple agonist just dropped a nuke on lipids and it’s not even Phase 3 finished yet. 48 weeks in and the numbers are looking PARABOLIC: • Non-HDL cholesterol down 26.9% • ApoB (atherogenic killer) down 24.2% • Triglycerides -40.6% • ApoC-III -38% • Big triglyceride - obliterated • Small dense LDL - obliterated HDL particle size improving, lipoprotein insulin resistance score dropping… this thing is cleaning house on the entire atherogenic profile.












